Literature DB >> 34793575

Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis-A multi-methods analysis of data from a multicentre survey.

Matthew Gaskins1, Mary Katherine Sammons1, Frank Kutscha1, Alexander Nast1, Ricardo Niklas Werner1.   

Abstract

BACKGROUND: While our knowledge of what motivates men who have sex with men (MSM) to use HIV pre-exposure prophylaxis (PrEP) has grown in recent years, quantitative survey-based studies have not asked MSM explicitly to name their motivations. We did so using a qualitative open-ended question and aimed to categorise the responses and explore whether these were related to where MSM were located along a conceptual continuum of PrEP care.
METHODS: In a multicentre survey examining knowledge and use of PrEP among MSM in Berlin, Germany, we additionally asked an open-ended question about motivations for using or considering PrEP. Data were collected from 10/2017-04/2018. One researcher developed a thematic framework deductively from the literature and another did so inductively from the free-text data, and a merged framework was used to code responses independently. We used Fisher's exact test to assess whether the frequency of motivations differed significantly between respondents using or considering PrEP.
RESULTS: Of 875 questionnaires, 473 were returned and 228 contained a free-text response. Motivations in the following categories were reported: (1) Safety/protection against HIV (80.2% of participants, including general safety; additional protection to condoms), (2) Mental well-being and quality of life (23.5%, including reduced anxiety; better quality of life), (3) Condom attitudes (18.9% intent not to use condoms), (4) Expectations about sexuality (14.4%, including worry-free sex or more pleasurable sex, with explicit mention of sex or sexuality), (5) Norms/social perspectives (0.8%). The difference in frequencies of motivations between those using or considering PrEP was not statistically significant.
CONCLUSIONS: Safety and protection against HIV, particularly having additional protection if condoms fail, were the most common motivations for using or considering PrEP, followed by mental well-being and quality of life. Many respondents reported several motivations, and responses overall were heterogeneous. This suggests that approaches to increase PrEP uptake that focus exclusively on its effectiveness in preventing HIV are unlikely to be as successful as a holistic approach that emphasises multiple motivations and how these fit into the broader sexual and psychological health of MSM.

Entities:  

Mesh:

Year:  2021        PMID: 34793575      PMCID: PMC8601504          DOI: 10.1371/journal.pone.0260168

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Men who have sex with men (MSM) continue to be the population most affected by HIV in the United States (US) and Europe, comprising 69% of new HIV diagnoses in the US [1] and 52% of new diagnoses (where the route of transmission was known) in the European Union (EU)/European Economic Area in 2018 [2]. An important and still relatively new tool to prevent HIV is pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate, which was approved for once-daily use in at-risk populations in the US in 2012 and in the EU in 2016. However, despite evidence of its high efficacy and safety [3-17], uptake among those at high risk of HIV acquisition has been slow. As of late 2019, approximately 224,000 people in the US were estimated to have received a prescription for PrEP, representing only a small proportion of the 1.1 million individuals estimated by researchers at the US Centers for Disease Control and Prevention (CDC) to have indications for it based on data from 2015 [18-20]. This is unfortunate given that the substantial declines in HIV incidence among MSM in London [21], San Francisco [22] and New South Wales, Australia [23], observed in the past several years are thought to be due, at least in part, to PrEP alongside other crucial prevention strategies such as treatment as prevention (TasP) and the continued promotion of condom use. In Berlin, the decline in HIV incidence among MSM has been smaller [24], and affordable PrEP has been accessible through formal channels in Germany only since autumn 2017. In Europe, where health policy makers and payers in many countries are still debating whether and how best to integrate PrEP into their publicly funded health systems and broader HIV prevention strategies [25-28], data on PrEP uptake are sparse. The most recent and comprehensive figures are from a 2019 study using data from the European MSM Internet Survey (EMIS-2017) to estimate the gap between self-reported PrEP use and expressed need for PrEP in the EU. Using this definition, the authors found that an estimated 17.4% of MSM, or 500,000 individuals, in the EU who were very likely to use PrEP were not able to access it [29]. At 12.6%, the PrEP gap for Germany in 2019 was smaller than the EU average [29], but not inconsiderable, and was similar to a finding of the first facility-based paper survey of PrEP use among MSM (N = 470) in Berlin in 2017/18, of which the current study is a part: in the survey, 12.9% of participants who reported never having used PrEP (who comprised 82.3% of the sample) strongly agreed with the statement that they would like to do so [30]. The most frequently reported barriers to PrEP use by these participants were worries about adverse effects, cost, not having a doctor who prescribes it, and, despite a high awareness of PrEP, a lack of information on its pros, cons and proper use [30]. To improve the implementation of PrEP, a range of authors over the past decade have proposed and refined several models of a continuum or “cascade” of PrEP care [31-37]. Most of the earlier models are largely based on a biomedical approach that assumes HIV prevention is the main priority in a person’s sexual decision-making and therefore evaluate this decision-making chiefly in terms of risk [38] and in a linear fashion. For example, the model proposed by Nunn et al. (2017) comprises nine steps ranging from identifying individuals at the highest risk of HIV to an end goal of retaining individuals in PrEP care [33]. In contrast, one of the more recent iterations of the PrEP care continuum, developed by Newman et al. (2018), follows a more holistic notion of personhood rooted in the results of their own qualitative analysis and the extensive anthropological and ethnographic literature on HIV prevention [37]. Their model considers the psychological, interpersonal, social and community phenomena that affect PrEP use and non-use, resulting in an augmented PrEP cascade that incorporates alternative decision-making, pathways (such as those with the end goal of intermittent use or discontinuation), and psychosocial impacts [37]. Regardless of the epistemological roots and approaches of these different models, however, what all of them share is that each stage in the proposed cascade represents a potential point of intervention to improve PrEP implementation among those for whom PrEP is a desired and viable option [32, 33]. At the same time, each of these steps is characterised by unique but overlapping sets of barriers and enablers that must be considered if we are to understand more fully how and why individuals move from one step to another–an understanding that is crucial to developing interventions to improve the implementation of PrEP, and HIV prevention strategies more generally, that are efficient, effective and, ideally, support the broader sexual and psychological health of MSM. Since 2012, evidence on the structural, sociocultural and behavioural barriers to PrEP implementation has grown considerably. These are manifold and include cost and lack of insurance coverage (e.g., [29, 39–43]), access to providers willing to prescribe PrEP (e.g., [18, 41, 44]), concerns among providers about increased sexual risk compensation (e.g., [29, 39]), but also, among those using or considering PrEP, concerns about side effects (e.g., [18, 39, 42, 43, 45]), stigma and discrimination (e.g., [18, 39, 43, 46–48]), and low perceived risk of infection (e.g., [18, 49–53]). Until recently, one significant gap in the literature was the lack of data on individuals’ motivations for taking PrEP. Indeed, in their comprehensive early review of research on the acceptability of PrEP and treatment as prevention (TasP), Young and McDaid (2014) identified motivations for PrEP use and adherence as one of the main areas in which further research was needed in order to identify “when, where and for whom PrEP and TasP would be most appropriate and effective” [45, p. 195]. A number of researchers, particularly in anthropological, ethnographic and other primarily qualitative lines of enquiry, have since stepped up to the plate to examine this topic. By exploring the subjective experiences of MSM in their navigation of PrEP, these authors have identified, mostly through in-depth interviews or in focus groups, numerous and varied motivations for using (or not using) PrEP that call into question the usefulness of biomedical approaches to PrEP implementation that de-emphasise psychosocial phenomena. In many cases, the motivations identified in these studies have stemmed from powerful affective experiences, such as being freed from sometimes decades-long, often cyclical anxiety about HIV infection [37, 38, 54, 55]; feeling empowered, able to make one’s own informed choices, in control or autonomous [37, 56]; and feeling less fear and shame in relation to pre-existing high-risk sexual behaviours alongside greater sexual satisfaction and intimacy [57, 58]. The qualitative literature also reports motivations related to fearing or experiencing PrEP-related stigma, such as beliefs that PrEP is only for those who are highly promiscuous [56, 59]; being labelled a “Truvada whore” (or similar) in lesbian, gay, bisexual, transgender, intersex and other gender diverse (LGBTI+) media, or by peers or even friends [60]; encountering provider-level stigma, including judgemental behaviour about the decision to use PrEP [35]; or experiencing, as a PrEP user or non-user, increased pressure to engage in condomless anal intercourse [37, 58, 61]. Among the studies that have explored motivations using survey-based quantitative methods, many have approached the subject in an indirect fashion using, for instance, correlation or regression analysis to identify factors associated with PrEP use, non-use, willingness to use PrEP or PrEP acceptability. A recent example is an analysis of data from a national, online, open-prospective observational study among MSM in Australia by Keen et al. (2020), who found that PrEP use was independently associated with lower levels of HIV anxiety among PrEP-eligible men [54]. Another example is the correlation between lower perceived HIV risk and PrEP non-use or PrEP discontinuation, which has been reported in large number of studies to date (e.g., [31, 51–53, 56, 58]). Furthermore, in a cross-sectional study of 164 HIV-negative MSM in HIV seroconcordant negative primary partnerships who were not taking PrEP, Gamarel et al. (2015) found that age, education and intimacy motivations for condomless sex were associated with PrEP adoption intensions in a multivariate model based on data elicited using interview-administered survey questions and assessment scales. Clearly, all of these factors can be interpreted as motivations for considering or using PrEP, but in none of the examples mentioned above did the survey participants actually describe them as such. Indeed, among this latter stream of the quantitative literature, we were unable to identify any surveys that explicitly asked MSM to name or describe their motivations for taking PrEP, whether by providing them with a list of pre-specified motivations or the possibility of writing a free-text response. While in-depth qualitative interviews and focus groups are probably the ideal way to explore the complex affective phenomena in this area of enquiry, there are several possible methodological advantages to eliciting such qualitative information using a self-administered survey tool: positioning an open-ended question amidst many closed questions might invite quick, spontaneous responses, and being open-ended it would, moreover, not be influenced by pre-specified categories or subjects (as would be the case with multiple choice items and/or the use of Likert scales) [62, 63]. Also, compared to data from a qualitative interview, the responses to such a question are more amenable to being coded and then analysed using a frequentist approach, and correlations with responses to the closed questions in the survey can be explored. The results can subsequently be reflected against those of previous, more in-depth qualitative research, with the aim of confirming, refuting, complicating or contextualising these. Moreover, whereas some previous work on different models of the PrEP care continuum has located participants of various cohorts along the respective cascade, to our knowledge no studies to date have attempted to identify whether the motivations of participants at one location in a PrEP care continuum might differ significantly from those at another location in the continuum. Lastly, it should also be noted that the focus of much of the qualitative and quantitative research on PrEP motivations to date has been on the US context, as well as on Australia, Canada and the United Kingdom. Perhaps not surprisingly given the four-year lag in the approval of PrEP in the EU/EEA [64], data from this region are minimal in comparison, and Germany is no exception in this regard. To help fill this gap in the literature, we conducted a multicentre, paper-based survey in late 2017/early 2018 of almost 500 MSM in Berlin with a self-reported negative or unknown HIV serostatus. In it, we explored participants’ knowledge and use of HIV pre-exposure prophylaxis using mostly closed questions. The results of this part of the survey are reported elsewhere [30]. The survey also had an open-ended question in which we explicitly asked participants who were using or considering PrEP to write what their main motivation was for doing so. In the current paper, we present the results of a multi-methods analysis of participants’ free-text responses to this question. Our primary aim was to identify, describe and categorise the motivations of MSM in Berlin to use or consider using PrEP. Additionally, drawing upon results from the quantitative part of the survey, we sought to explore whether motivations differed between participants who had already started taking PrEP and those who were still considering it. Such information could help clinicians, sexual health counsellors and policy makers develop and distribute targeted information and advice to individuals at several steps of the PrEP care continuum and thereby improve the implementation of PrEP in Germany and beyond.

Materials and methods

Study design, ethics approval and informed consent

We used an anonymous, self-administered, paper-based questionnaire, available in German and English, to conduct a multicentre, cross-sectional survey of MSM in Berlin. The local institutional ethics committee at Charité–Universitätsmedizin Berlin approved the study protocol, the format and content of the questionnaire, and the information cover sheet for participants (EA1/162/17; 28/09/2017). All participants gave informed verbal consent to their physician or sexual health counsellor in English or in German before filling in the questionnaire. Participation was voluntary, and neither the centres nor the participants received any incentives to take part. The survey period was from 1 October 2017 to 2 April 2018. The questionnaires and information cover sheet can be accessed in full, in both English and German, in the publication of the quantitative study results by Werner et al. (2018) [30].

Sampling methods, participants and settings

To be eligible, participants had to identify as male, be aged 18 years or older, report having sex with men, and have a self-reported negative or unknown HIV status. We collected data from a range of settings, namely all four non-municipal counselling and testing centres for the sexual health of LGBTI+ people, as well as six large HIV specialist practices in Berlin. The former are non-commercial walk-in centres funded by the state government of Berlin and through private donations. They offer a range of low-barrier services, including community outreach and anonymous counselling on legal, immigration and health issues for LGBTI+ adults and adolescents, as well as affordable testing for STIs, including HIV. They are not permitted by law to prescribe medication. All clients attending the walk-in centres for STI screening or counselling were offered participation in the study by the centre staff. HIV specialist practices in Germany offer a full range of generalist and sexual health services to LGBTI+ people regardless of whether they are living with HIV, and indeed can serve as the designated GP/family doctors for these individuals. The practices are owned and staffed by physicians, and consultations usually require an appointment, but walk-ins are possible. In total, 11 such practices from seven districts in Berlin were invited to participate in the study. We chose these purposively based on their geographic spread across Berlin and our awareness that they had been willing to take part in previous research projects related to HIV and other STIs. In these practices, we asked doctors to include every eligible patient, irrespective of the reason for the consultation, in a consecutive manner. During the data collection period (1 October 2017 to 2 April 2018), PrEP was available in Germany only by means of a private prescription, which could be written by any licensed doctor. About half way through this period, the price of a month’s supply of generic PrEP in Germany fell from approximately 600 euros to as low as 50 euros [30]. The relevant guideline for identifying at-risk patients and prescribing PrEP is the German and Austrian Guideline on HIV pre-exposure prophylaxis [65], but its recommendations are not binding. The German system of statutory health insurance began to cover the costs associated with PrEP in September 2019. All of the HIV and STI testing and counselling centres in Berlin (n = 4) participated in the study, as did six of the 11 HIV specialist practices we had invited. Of the 875 questionnaires distributed by the participating centres, 473 were returned (response rate 54.1%). Three participants were excluded because they reported in the questionnaire that they were living with HIV. Of the remaining 470 questionnaires, 259 contained a free-text response to the question about participants’ main motivation for using PrEP or considering its use. Thirty one of these responses were considered invalid because the participants had disagreed/strongly disagreed with the statement “I would like to take PrEP” (n = 30) or because they responded “no” to the question whether they had ever used PrEP but had indicated in their response to the statement “I would like to take PrEP” that it was not applicable to them because they were already taking it (n = 1). This resulted in a sample of 228 questionnaires with a valid free-text response for analysis.

Questionnaire format and content

The questionnaire was two pages in length and consisted mostly of closed, multiple-choice questions on participants’ knowledge and use of HIV pre-exposure prophylaxis, as well as demographic data and information on their sexual behaviour and HIV risk. Additionally, the survey had the following open-ended question: “If you are considering or already using PrEP, what is your main motivation for this?” The question gave space for responses of one to two sentences. A cover page gave a brief description of PrEP and explained the purpose of the survey.

Qualitative data analysis

We defined our units of analysis as the individual motivations for using or considering PrEP rather than the free-text response as a whole. We applied a framework analysis approach to code each motivation, using high-level themes to categorise the data [66]. To help ensure that the analysis was not driven primarily by our theoretical interests and analytic preconceptions, we took a combined deductive and inductive approach to developing the coding framework [66, 67]: One researcher (RNW) created a set of categories and subcategories deductively based on the findings of a structured search of the literature for existing frameworks and models for characterising motivations for PrEP use, whereas a second researcher (MS) created a separate set of categories and subcategories inductively based on a pilot coding and analysis of a randomly selected subset of 75 free-text responses. These two classification systems were subsequently merged by the two researchers through discussion, with discrepancies and disagreements resolved by consensus in a series of meetings facilitated by a third researcher (MG). The first researcher (RNW), who created a set of categories and subcategories deductively, took the following approach: To identify studies or reviews reporting a classification system or listing categories of motivations to use PrEP, he searched MEDLINE on 4 April 2018 using the search terms “motivation” and “PrEP”, with time limits set to the five years before this date. Categories identified in the literature were noted without further assessment of the quality of the studies. The search yielded 61 records whose abstracts and titles were screened for eligibility, yielding six records to be evaluated in full text [51, 58, 68–71]. Two of these studies were used to derive an initial categorisation system for motivations: Dubov et al. (2018) reviewed factors associated with PrEP uptake and categorised these factors along the Information-Motivation-Behavioural Skills model [51]. Their construct of motivation comprised four domains, each of which is attributed various further subdomains. Frankis et al. (2016) analysed qualitative data from in-depth interviews to deduce motivations for potential PrEP use, including situations of increased need for protection from acquiring HIV [68]. The second researcher (MS), who developed a set of categories and subcategories inductively, took the following approach: first, the third researcher (MG) familiarised himself with the entire qualitative dataset by reading and re-reading all free-text responses to make a pragmatic assessment of the number of these that would need to be coded before saturation was reached (i.e., roughly one third of all valid responses). Subsequently, a list of randomly generated numbers was appended to the qualitative dataset, and the responses numbered between one and 75 were sent to the second researcher for pilot coding. Coding was undertaken in a manner that was both open (i.e., with codes being assigned to describe as many perspectives as possible, such as particular behaviours, intentions, values, beliefs and emotions) [66] and circular (i.e. looping or cycling repeatedly between the qualitative codes assigned to the data and the data itself, and recoding, considering emergent categories, and recategorising as needed) [72]. After the two classification systems had been merged, the final categories comprised: safety/protection against HIV, expectations about sexuality, mental well-being and quality of life, condom attitudes, and norms/social perspectives. Table 1 gives an overview of the categories and subcategories in our coding system, providing definitions for each, as well as references to the pertinent literature.
Table 1

Overview of final coding framework and categorisation system with definitions (categories and subcategories listed in alphabetical order).

CategorySubcategory
CONDOM ATTITUDES [51] Desire or intent to engage in condomless sex
Responses are coded in this subcategory if they refer to the desire or intent to engage in condomless sex. Negative attitudes towards condom use and reporting episodes of condomless intercourse have been described as being associated with the intention to use PrEP [73].
This category comprises two subcategories for coding responses that refer to respondents’ attitudes towards condom use.
Difficulties with condom use
Responses are coded in this subcategory if they mention difficulties with condom use as a motivation to use PrEP [55].
EXPECTATIONS ABOUT SEXUALITY Expectations of more pleasureful sex or increased intimacy and closeness (when not using a condom)
Responses are coded in this subcategory if they include the expectation of more pleasureful sex, intimacy or closeness as a motivation to use PrEP, irrespective of whether the response refers to using condoms. Believing that condoms reduce intimacy and closeness and/or sexual pleasure is a factor that has been described as associated with the intention to use PrEP [37, 55, 58].
This category comprises two subcategories for coding responses that refer to respondents’ expectations about sexuality while using PrEP.
Expectations of worry-free sex
Responses are coded in this subcategory if they refer to the expectation of worry-free or less worrisome sex as the motivation for using PrEP [37]. In contrast to the subcategory “Reducing anxiety, fear, or worries of being infected with HIV” under the category “Mental well-being and quality of life”, responses here had to mention sex or sexuality explicitly.
MENTAL WELL-BEING AND QUALITY OF LIFE Desire for a healthy life
Responses are coded in this subcategory if they refer to the general desire to increase health or longevity, or to lead a healthy life.
This category comprises four subcategories for coding responses that refer to respondents’ mental well-being or aspects of general health. Desire to increase quality of life or sexual/personal freedom
Responses are coded in this subcategory if they refer to the desire to increase quality of life, mental well-being, general health, or sexual or personal freedom as the motivation to use PrEP [37].
Reducing anxiety, fear, or worries of being infected with HIV
Responses are coded in this subcategory if they include the desire to reduce anxiety, fear or worries about being infected with HIV [37, 38, 54, 55]. Unlike the subcategory “expectations of worry-free sex”, this subcategory does not include responses that refer explicitly to the act of sex.
Reducing periods of anticipated regret
Responses are coded in this subcategory if they included the desire to decrease periods of anticipated regret or worries. The cognitive-based emotion of anticipated regret from engaging in HIV-risk behaviour has been described as an important determinant of the intention to use PrEP [51].
NORMS / SOCIAL PERSPECTIVES Perceiving condomless sex / PrEP intake as a social norm
Responses are coded in this subcategory if the answer refers to perceptions of PrEP use as a social norm or the need to use PrEP as the only means of personal protection in a social environment that insists on condomless sex [37, 58, 61].
This category comprises two subcategories for coding responses that refer either to perceptions of PrEP use as a social norm or that reflect upon PrEP use in terms of social or public health perspectives.
Prevention altruism [51]
Responses are coded in this subcategory if the respondent refers to a general public health perspective of reducing the burden of HIV epidemics. General public health concerns have been described as a facilitator of engaging in safer sex practices [74].
SAFETY/PROTECTION AGAINST HIV Additional protection against HIV
Responses are coded in this subcategory if they reflect the respondent’s wish to have additional protection against HIV, or additional safety or security, by using PrEP as a “backup preventive strategy”. This has been described in the literature as a specific motivation to use PrEP [68]. Safer sex intentions have been shown to be linked with the motivation to use PrEP [73].
This category comprises eight subcategories for coding responses that refer to protection against HIV or general safety considerations, as well as more specific aspects of protection or safety for oneself or for others.
Autonomy and self-empowerment in the protection against HIV
Responses are coded in this subcategory if they reflect the respondent’s wish to protect himself from being infected with HIV using a method of protection that lies within his own responsibility and is not dependent on his partners’ reliability or will to use condoms [37, 56].
Being at self-perceived risk of HIV
Responses are coded in this subcategory if they reflect the respondent’s general perception of being at risk of acquiring HIV due to specific circumstances, such as having sex with many casual partners or being in a relationship with a person living with HIV. Self-perceived risk of acquiring HIV has been described as a factor that may motivate individuals to seek preventive services. Considering oneself as being at risk of HIV infection has been shown to be correlated with self-perceived eligibility for PrEP use [31, 5153, 56, 58].
PrEP as an affordable way to protect against HIV
Responses are coded in this subcategory if they mention the affordability or cost of PrEP as an option to protect oneself from being infected with HIV.
Protecting partner(s) or relationship(s) from HIV infection
Responses are coded in this subcategory if they reflect the respondent’s wish to protect his (sex) partners’ health or well-being or if the answers included relationship-associated aspects. Attitudes towards using PrEP have been shown to be linked with considerations of protecting primary and/or outside partners [55, 73]. Concerns for the sexual partners’ risk of acquiring HIV and general public health concerns have also been described as a facilitator of engaging in safer sex practices [74].
Protection against HIV during periods of anticipated increased risk (e.g., recreational drug use, holidays)
Responses are coded in this subcategory if they reflect the respondent’s wish to protect himself from being infected with HIV during specifically defined events (e.g., recreational drug use) or periods (e.g., holidays) that are accompanied by an anticipated increased risk of being infected with HIV. PrEP has been described as an option for situations in which regular patterns of sexual practice might be disrupted, such as holidays or in the event of alcohol and/or drug use [53, 68].
Protection against HIV, prevention of HIV and general safety
Responses are coded in this subcategory if they reflect the respondent’s general wish to protect himself from being infected with HIV, or his generally expressed need for safety, without mentioning specific circumstances or specifying aims beyond (his individual) protection.
Protection against HIV when not using condoms
Responses are coded in this subcategory if they reflect the respondent’s wish to protect himself from being infected with HIV explicitly without having to use condoms.
Two researchers (RNW, MS) subsequently used this framework independently to identify, code and classify individual motivations in each free-text response (including the 75 responses used in the pilot coding). Meetings among all three researchers were held at regular intervals during the coding and classification process to discuss potential emerging new categories or subcategories during the coding. Ultimately, no substantial changes to the framework were needed during this process, although we did clarify the definition for the subcategory “Expectations of worry free-sex” to require, in contrast to the subcategory “Reducing anxiety, fear, or worries of being infected with HIV”, the explicit mention of sex or sexuality. Moreover, a subcategory “Desire to increase quality of life or sexual freedom” was broadened to include “sexual/personal freedom”. Furthermore, even though the number of responses in the category “Norms / social perspectives” was minimal, we decided to retain it because of its prominence as a finding in the qualitative literature (e.g., [37, 58, 61]) and our desire not to take an overly frequentist approach to reporting the qualitative data. Lastly, while preparing the manuscript we decided to use the term “quality of life” instead of “general health” to describe the category “Mental health and quality of life” because we felt the term better captured the nature of the responses we had assigned to various subgroups in this category. There was a high degree of agreement between the coding results of the two researchers (Cohen’s Kappa = 0.837, 95% CI: 0.794–0.880). The third researcher (MG) reviewed all disagreements and resolved these with the other researchers through discussion.

Quantitative data analysis

No formal sample size calculations were performed for the survey. Based on feasibility considerations, we aimed at collecting data from approximately 500 participants. Data were analysed using descriptive statistics and Fisher’s exact test of independence to assess whether the frequency of motivations for PrEP, by category, differed in a statistically significant manner (alpha level 0.05) between the subset of the sample that reported using PrEP or having a history of its use and the subset that reported considering PrEP. In our data set, we classified respondents who indicated no previous PrEP use, reported a motivation, and did not disagree or strongly disagree with the statement that they would like to use PrEP as considering PrEP use. Within all of the models of the PrEP care continuum developed to date, this group could be located at any of the steps before the step corresponding to PrEP initiation (e.g., “Initiate PrEP” in the model by Newman et al. (2018) [37], Stage 4b of “Stage 4: PrEP action and initiation” in the model by Parsons et al. (2018) [34], or “Step 7: Initiating PrEP” in the model by Nunn et al. (2017) [33]). Respondents who reported that they were currently using PrEP or had used it in the past (i.e. “Yes, but not on a regular basis”, “Yes, I regularly use it before and after risk sex (as needed)”, “Yes, I use it continuously”), reported a motivation, and did not disagree or strongly disagree with the statement that they would like to use PrEP were classified as using PrEP or having a history of its use. This group could be located, roughly, in “Stage 5: PrEP maintenance and adherence” of the model by Parsons et al. (2018) or at steps 8 (“Adhere to PrEP”) or 9 (“Retention in PrEP Care”) of the model by Nunn et al. (2017). However, because we included people with different PrEP trajectories (i.e., those who had used PrEP in the past but were not necessarily taking it at present), they would be more appropriately placed between the steps “Initiate PrEP” and “Retention”, with the possibility of being located at the stages “Seasonal or intermittent use” or “Discontinuation” on the augmented PrEP cascade of Newman et al (2018) [37]. For any post-hoc pairwise comparisons, we applied a Bonferroni-corrected alpha level of 0.05 divided by the number of compared pairs to account for multiple testing. To avoid a purely frequentist approach and preserve the richness of our qualitative data when reporting examples of motivational factors given in response to the open question, we chose to cite whenever possible five motivations that summarised the overall body of motivations in each subcategory, whether responses in this subcategory were frequent or rare. In cases where fewer or more than five motivations were sufficient or needed for this purpose, a different number of responses is cited. Statistical analyses were performed using Stata SE version 14.2.

Results

Demographic data, sexual behaviour and HIV risk of analysis sample

Among the 228 respondents who gave a valid free-text response to our question about motivation, 65 were using PrEP or had used it at some point in the past, and 163 were considering it. Their mean age was 36.4 years (SD 10.8, range 20–79). Table 2 shows these and other demographic and sexual risk behaviour data for these respondents (analysis sample), as well as separately for those who were using PrEP (or had a history of its use) and those who were considering it. Differences between these latter two subgroups were minor and similar to the roughly analogous subgroups reported in the publication on the quantitative results of the survey [30].
Table 2

Demographic data and sexual risk behaviour of participants who answered the question about their motivation for using or considering PrEP.

Analysis sampleParticipants using PrEP (or with history of its use)Participants considering PrEP use
N = 228N = 65N = 163
Age
Mean (SD) in years36.4 (10.8)33.9 (6.9)37.3 (11.8)
Min-max in years20–7924–5320–79
Not stated954
Highest degree or level of school (N, %)
Primary education0 (0.0%)0 (0.0%)0 (0.0%)
Secondary education up to year 10*21 (9.2%)3 (4.6%)18 (11.0%)
Secondary educ. with apprenticeship11 (4.8%)1 (1.5%)10 (6.1%)
Secondary education up to year 12**41 (18.0%)7 (10.8%)34 (20.9%)
University degree151 (66.2%)50 (76.9%)101 (62.0%)
Not stated4 (1.8%)4 (6.2%)0(0.0%)
Financial situation (N, %)
Not always have enough money19 (8.3%)7 (10.8%)12 (7.4%)
Enough money104 (45.6%)25 (38.5%)79 (48.5%)
More than enough money102 (44.7%)30 (46.2%)72 (44.2%)
Not stated3 (1.3%)3 (4.6%)0 (0.0%)
Place of residence (N, %)
Berlin213 (93.4%)60 (92.3%)153 (93.9%)
Other city in Germany7 (3.1%)1 (1.5%)6 (3.7%)
Small town / rural area in Germany0 (0.0%)0 (0.0%)0 (0.0%)
Other country5 (2.2%)1 (1.5%)4 (2.5%)
Not stated3 (1.3%)3 (4.6%)0 (0.0%)
Family origins (N, %)
Participant & both parents born in Germany132 (57.9%)29 (44.6%)103 (63.2%)
One parent born outside Germany17 (7.5%)7 (10.8%)10 (6.1%)
Both parents born outside Germany19 (8.3%)7 (10.8%)12 (7.4%)
Participant born outside Germany56 (24.6%)19 (29.2%)37 (22.7%)
Not stated4 (1.8%)3 (4.6%)1 (0.6%)
Current HIV status (N, %)
HIV negative198 (86.8%)61 (93.8%)137 (84.0%)
Not sure24 (10.5%)0 (0.0%)24 (14.7%)
Not stated6 (2.6%)4 (6.2%)2 (1.2%)
STI diagnosis in the past six months (N, %)
No168 (73.7%)37 (56.9%)131 (80.4%)
Yes57 (25.0%)25 (38.5%)32 (19.6%)
Not stated3 (1.3%)3 (4.6%)0 (0.0%)
Role when having anal sex (N, %)
No anal sex7 (3.1%)0 (0.0%)7 (4.3%)
Bottom only21 (9.2%)6 (9.2%)15 (9.2%)
More bottom than top60 (26.3%)15 (23.1%)45 (27.6%)
Top and bottom (versatile)58 (25.4%)19 (29.2%)39 (23.9%)
More top than bottom49 (21.5%)12 (18.5%)37 (22.7%)
Top only30 (13.2%)10 (15.4%)20 (12.3%)
Not stated3 (1.3%)3 (4.6%)0 (0.0%)
Number of anal sex partners in the past six months (N, %)
None14 (6.1%)0 (0.0%)14 (8.6%)
122 (9.6%)2 (3.1%)20 (12.3%)
2 to 567 (29.4%)12 (18.5%)55 (33.7%)
6 to 1044 (19.3%)13 (20.0%)31 (19.0%)
More than 1076 (33.3%)35 (53.8%)41 (25.2%)
Not stated5 (2.2%)3 (4.6%)2(1.2%)
Number of anal sex partners without using condom in the past six months (N, %)
None62 (27.2%)6 (9.2%)56 (34.4%)
154 (23.7%)7 (10.8%)47 (28.8%)
2 to 571 (31.1%)23 (35.4%)48 (29.4%)
6 to 1021 (9.2%)11 (16.9%)10 (6.1%)
More than 1017 (7.5%)15 (23.1%)2 (1.2%)
Not stated3 (1.3%)3 (4.6%)0 (0.0%)

STI, sexually transmitted infection

*or similar

**for example A levels, high school diploma, German “Abitur”.

STI, sexually transmitted infection *or similar **for example A levels, high school diploma, German “Abitur”. See S1 Table for a comparison of the demographic data and sexual risk behaviour of participants in our analysis sample and respondents who indicated that they were neutral about or might be interesting in taking PrEP but did not provide a free-text answer to the question about their motivation (n = 104). The latter group was very similar to our analysis sample in terms of age, educational attainment and place of residence, but was different to it insofar as a substantially larger proportion of respondents were less financially secure, were unsure about their HIV status, had never used PrEP and reported engaging in sexual behaviour that put them at lower risk of HIV infection.

Motivations of the participants

The number of motivations cited by participants ranged from one to five (mean: 1.38, median: 1.0). More specifically, of the 228 responses to the question about participants’ motivation for using or considering PrEP, we coded 152 as describing one motivation, 66 as describing two motivations, 9 as describing three motivations, and 1 as describing five motivations. All free-text responses that contained multiple motivations reported these clearly as part of a list using the conjunctions “and” or “but”, a comma or other form of punctuation, or some combination of these. Table 3 gives an overview of the different categories of motivations and the number of respondents who reported one or more motivations exclusively in each category (or combination of categories). Of the 228 respondents, 154 reported some form of safety and protection against HIV as either their only motivation (n = 121) or one of their motivations (n = 33) for using or considering PrEP. This was followed by 50 respondents who reported some form of mental well-being and quality of life as either their only motivation (n = 23) or one of their motivations (n = 27). A total of 43 respondents reported condom attitudes (i.e., a desire or intention to engage in condomless sex) as either their only motivation (n = 21) or one of their motivations (n = 22). Lastly, 31 respondents reported some form of expectations about sexuality as either their only (n = 14) or one of their motivations (n = 17). Only two respondents reported norms and social perspectives as their only motivation for using or considering PrEP. Among those respondents who reported two motivations in total, the only combinations of motivations that comprised at least approximately 5% of the analysis sample were in the categories safety and mental well-being (12 respondents, 5.3%) and safety and condom attitudes (10 respondents, 4.4%). The difference in the frequencies between the two subsamples was not statistically significant (Fisher’s exact test, p = 0.234). A post hoc pairwise comparison of the frequencies also revealed that none of them differed in a statistically significant manner between the groups when the alpha level was set to 0.003 (i.e., 0.05/13).
Table 3

Participants reporting one or more motivations exclusively in a category or combination of categories in the analysis sample, by subgroup (using or considering PrEP).

Category of motivation(s) for using or considering PrEPParticipants in analysis sampleParticipants using PrEP (or with history of its use)Participants considering PrEP use
N = 228N = 65N = 163
Safety121 (53.1%)30 (46.2%)91 (55.8%)
Mental well-being23 (10.1%)7 (10.8%)16 (9.8%)
Condom attitudes21 (9.2%)4 (6.2%)17 (10.4%)
Expectations14 (6.1%)4 (6.2%)10 (6.1%)
Norms2 (0.9%)1 (1.5%)1 (0.6%)
TOTAL RESPONDENTS 181 46 135
Safety & mental well-being12 (5.3%)4 (6.2%)8 (4.9%)
Safety & condom attitudes10 (4.4%)4 (6.2%)6 (3.7%)
Safety & expectation6 (2.6%)5 (7.7%)1 (0.6%)
Expectations & mental well-being6 (2.6%)3 (4.6%)3 (1.8%)
Expectations & condom attitudes4 (1.8%)1 (1.5%)3 (1.8%)
Mental well-being & condom attitudes4 (1.8%)1 (1.5%)3 (1.8%)
TOTAL RESPONDENTS 42 18 24
Safety, mental well-being & condom attit.4 (1.8%)1 (1.5%)3 (1.8%)
Safety, expectations & mental well-being1 (0.0%)0 (0.0%)1 (0.6%)
TOTAL RESPONDENTS 5 1 4
Looking at the subcategories of motivations adds more granular information and complexity to this picture. In the safety category, responses citing general aspects of safety and protection against HIV predominated (mentioned by 40.4% of respondents), but were followed by more specific motivations, such as PrEP serving as additional protection above and beyond condom use (16.2%), being at risk of HIV infection (7.5%), or seeking protection against HIV when not using condoms (6.1%). Nine respondents (0.04%) mentioned safety or protection in relation to protecting others as opposed to themselves. In the condom attitudes category, 18.0% percent of respondents explicitly mentioned a desire to engage in condomless sex as a motivation for using or considering PrEP. Expectations about sexuality, as a category, included explicit mentions of anxiety- or worry-free sex (8.3%) and of more pleasurable sex (6.1%) as motivations. Lastly, the category of mental well-being and quality of life included motivations related to reducing anxiety, fear or worries of being infected with HIV (8.6%) and a desire to increase quality of life or sexual and personal freedom (8.3%). Table 4 gives examples of the motivations ordered along these categories; responses in German were translated into English for presentation in the table by one researcher (MG) and checked independently by the remaining authors, with disagreements resolved by consensus.
Table 4

Qualitative results: Survey respondents’ motivations for using or considering PrEP according to category and subcategory, their frequency, and representative examples.

CATEGORY: SAFETY/PROTECTION AGAINST HIV
Subcategory Frequency Example motivations
General safety/Protection against HIV/Prevention of HIV92/228 (40.4%)“To protect myself from HIV”
“Reduce the chance of HIV infection”
“Safety regarding HIV infection”
“HIV prophylaxis”
“Health protection”
Additional protection against HIV37/228 (16.2%)“Additional safety when having sex”
“Backup”
“I want extra protection in case a condom fails or if I make a bad decision.”
“To protect myself from HIV if the condom slips off or loses its protection for some other reason”
“Protection (double, with condom)”
Being at self-perceived risk of HIV17/228 (7.5%)“HIV-infected partner who has just begun therapy”
“It has happened in the past, even though I didn’t intend to, that I had sex without a condom”
“Many casual sex partners from time to time”
“Protection, I live in a long-term relationship with an HIV positive guy”
Protection against HIV when not using condoms14/228 (6.1%)“To feel safer in case of unprotected sex”
“Easy protection when having sex without a condom”
“Sex without a condom and hardly any risk of infection”
“Protection against HIV without a condom”
Autonomy and self-empowerment9/228 (3.9%)“To protect myself more actively and not rely on others, for example regarding a condom”
“More autonomy as (I am) more a bottom”
“I have more safety and don’t have to depend on my partner keeping the condom on”
“Because I find it hard to trust people, so as a way to be more careful.”
“More control”
Protecting partner(s) or relationship(s)9/228 (3.9%)“To protect health (mine, of my partner & of my sex partner)"
“To protect my opposite”
“Protection for me and others”
“Greater security in an open relationship”
“The knowledge that I can’t harm anybody with my actions”
“My partner has HIV and we’re in an open relationship”
Protection against HIV during periods of anticipated increased risk (e.g. recreational drug use, holidays)5/228 (2.2%)“To avoid accidents when I’m in environments that may affect my decisions and behaviour. At a party or around the time I go for a party. I am afraid that alcohol consumption or simply condom break may expose me to HIV.”
“Addition protection during special occasions (e.g., holiday)”
“I have more security and don’t have to rely on (. . .) myself, even under the influence of alcohol, insisting on a condom in every situation”
“Protection against stupidity when drinking alcohol”
PrEP as an affordable protection against HIV2/228 (0.0%)“Protection, low costs”
“It seems like an affordable option and viable way to help protect against HIV infection.”
CATEGORY: MENTAL WELL-BEING AND QUALITY OF LIFE
Subcategory Frequency Example motivations
Reducing anxiety, fear or worries of being infected with HIV17/197 (8.6%)“Paranoia, fear of getting infected”
“Not constantly having to be afraid”
“Less anxiety before the next HIV test”
“My whole life there’s only been sex with a condom and fear of HIV”
“To free myself from fear”
“Although I’m putting myself at risk of getting an STD, I find the benefits of PrEP overwhelmingly because I no longer have to fear that I’ll get HIV”
Desire to increase quality of life or sexual / personal freedom19/228 (8.3%)“Peace of mind”
“Convenience”
“Quality of life”
“Not always (….) having to take PEP”
“Personal freedom”
“Sexual freedom”
“A feeling of security”
“Uncomplicated sex”
“Spontaneous sex (…) also with casual partners”
“I’d like to try a few sex partners who I otherwise couldn’t (try out) without being on PrEP”
“So I can behave more like heterosexuals and not worry every time I choose not to use a condom”
Reducing periods of anticipated regret8/228 (3.5%)“The psycho-stress after unprotected sex”
“No guilty conscience about unsafe sex”
“To not feel regret after unsafe sex”
“Less chance for my imagination to run away from me” (“weniger Kopfkino”)
“To have a better conscience after having unsafe sex”
Desire for a healthy life7/228 (3.1%)“To protect (my) health”
“To not become ill”
“Longer life”
“Health”
“Stay healthy”
CATEGORY: CONDOM ATTITTUDES
Subcategory Frequency Example motivations
Desire or intent to engage in condomless sex41/228 (18.0%)“I don’t like condoms”
“Anal sex without a condom”
“Unsafe sex”
“Unprotected sex”
“To have sex without condom with known sexual partners that test for other STDs regularly”
“Unprotected sex with partner”
“To have riskier sex”
Difficulties with condom use2/228 (0.9%)“Protection from HIV because I can’t deal with condoms”
“Problem with condom when being a top”
CATEGORY: EXPECTATIONS ABOUT SEXUALITY
Subcategory Frequency Example motivations
Expectations of worry-free sex19/228 (8.3%)“It’s a way to feel safer when having sex”
“More relaxed approach to sexuality”
“Unencumbered Sex”
“Sex without fear”
“To have riskier sex without fear”
“Carefree sex without worrying about HIV infection”
Expectations of more pleasureful sex14/228 (6.1%)“More pleasure”
“Sex is more intense”
“To enjoy sex”
“To (…) enjoy sex more”
“Intense feeling during sex”
“More sensuality, more pleasure”
CATEGORY: NORMS / SOCIAL PERSPECTIVES
Subcategory Frequency Example motivations
Perceiving condomless sex/PrEP intake as a social norm1/228 (0.4%)“More and more guys are doing bareback sex only”
Desire to eradicate HIV1/228 (0.4%)“Eradicating HIV”

Discussion

Our study is the first multicentre, paper-based survey to ask MSM in Berlin explicitly to name their motivations for using or considering HIV PrEP. By a large margin, most respondents who answered the question cited some form of safety and protection against HIV as their only motivation or one of their motivations in this regard. Most frequently in this category, respondents mentioned being motivated by the idea of having additional protection in case of condom failure (e.g., “To protect myself from HIV if the condom slips off or loses its protection for some other reason”, “Additional safety when having sex”). Even though some 18% of respondents in our analysis sample explicitly mentioned a desire or intent to engage in condomless sex as a motivation for using or considering PrEP, these findings about safety and protection should reassure payers and practitioners who might be focusing disproportionately on the subject of sexual risk compensation, i.e., an increase in sexual behaviours that could put those who engage in them at a higher risk of infection with HIV and other STIs [75-80]. Indeed, the second most frequently cited category of motivations among our respondents after that of safety and protection was that of mental well-being and quality of life. Given the alarming frequency of suicide, depression and self-harm among sexual minorities, for which there is an abundance of evidence worldwide (e.g., [81-83]), our results suggest that it might be wise to attach greater weight to these beneficial effects of PrEP when deciding on its appropriateness for a given patient–and perhaps somewhat less weight than hitherto to the understandable but still largely theoretical concern of increased sexual risk compensation and STI incidence, for which the evidence is mixed [84-86]. This latter finding resonates with the results of qualitative studies that have engaged with this area of enquiry, challenging the predominant biomedical approach to PrEP implementation. With regard to motivations such as those to reduce HIV anxiety, improve self-efficacy, be able to make one’s own informed choices, and feel less fear and shame, for example, our respondents wrote short but powerful responses about “not constantly having to be afraid,” living a “whole life” in which “there’s only been sex with a condom and fear of HIV”, wanting to “try a few sex partners who I otherwise couldn’t without being on PrEP”, and no longer having to “feel regret” or have “psycho-stress” after having “unprotected” or “unsafe” sex. Examining such phenomena, and affective experiences more generally, is crucial because these have been shown to have a profound impact on the sexual and psychological well-being of MSM (e.g., [35, 37, 38, 57, 59, 60]). Moreover, these motivations are also tied to ongoing decision-making about PrEP that is based on sexual risk and relationship trajectories that have been shown to be varied and dynamic [37]. This idea of moving beyond a circumscribed biomedical approach to PrEP implementation is supported by a further, and somewhat unexpected, result from our study: Even though our survey item asked only for respondents’ main motivation for using or considering PrEP, one third (76/228) of our respondents nevertheless reported more than one motivation. Although these multiple motivations often fell into the same category (most frequently into that of safety and protection), it is important to bear in mind that even in a category as seemingly one-dimensional as “safety and protection”, a broad range of subcategories could be identified, including protection during periods of anticipated increased risk, self-perceptions of being at high risk, and additional protection against HIV while using a condom. Moreover, some 20% (47/228) of respondents reported motivations in more than one category. Altogether, this suggests that approaches to PrEP counselling that seeks, where appropriate, to increase the uptake of PrEP by focusing exclusively on its effectiveness in preventing HIV is unlikely to be as successful as a holistic approach that focuses simultaneously on multiple motivating factors, particularly those related to mental health and quality of life. While this may be something that any good doctor, sexual health counsellor or social worker would do, the results of our study might nevertheless be useful as a reminder of the breadth of motivations that can influence the decision to use PrEP and encourage practitioners to seek to identify multiple (and, indeed, even apparently contradictory) factors in individual patients. This may also aid decisions to inform patients about other preventive strategies, and to provide support with broader sexual and psychological health issues, as part of a more holistic approach. The idea of taking a more holistic approach to PrEP implementation has been the focus of several recent publications. Lacombe-Duncan et al. (2021) drew on qualitative data from in-depth, semi-structured interviews with 29 MSM recruited purposively in 2015/16 in a community setting in Toronto, Canada, to identify and explore gaps in PrEP implementation that might be amenable to social work intervention [61]. Among other results, they found that MSMs’ navigation of sexual health and risk practices was made complex by a range of sometimes contradictory factors encompassing the individual, interpersonal, organisational and structural levels. This aligns very much with the breadth of motivations reported in our survey, as well as the reporting of multiple motivations by individual respondents. Lacombe-Duncan et al. (2021) make clear that addressing such factors and, more specifically, the social determinants of health and psychosocial issues that affect PrEP engagement solely in terms of HIV infection risk and a binary decision about PrEP uptake would be wholly inadequate to support individuals with informed decision making [61]. A recently published systematic review by Pinto et al. (2018) corroborates these and, in part, our findings, and identifies the need for a range of multilevel interventions targeting multiple socioecological domains, such as interventions to help people navigate health care systems and improve referrals to mental health and supportive services, as well as provider-level interventions such as increased training and education about PrEP [43]. In their scoping review of PrEP service delivery and programming, Hillis et al. (2020) also identify a range of potentially useful multidisciplinary and innovative PrEP care pathways; however, they make the important additional point that PrEP provision in a health system actually creates new opportunities for MSM to access health services to which they might not otherwise have availed themselves, such as sexual health care, testing, treatment, counselling and STI testing and psychological support [87]. A further aim of our study was to determine whether motivations differed between individuals at two different locations on a conceptual continuum of PrEP care: those who were using it or had used it at some point in the past and those who were contemplating or considering its use. Contrary to our expectations, we were unable to identify statistically significant differences in motivations between the groups that might inform targeted approaches to increase uptake or improve adherence. From a qualitative research perspective, however, it is of value to point out that some of the differences appeared substantial and would be worthy of further investigation, ideally applying methods and a study design that would allow for quantitative hypothesis testing as well as in-depth qualitative questioning of findings. In particular, it appears that participants considering PrEP may have been more likely to cite safety as their only motivation whereas motivations in combination with the category of safety played a greater role among those using PrEP or with a history of its use. While this may be due to social desirability bias in survey research, it is conceivable that once individuals have initiated PrEP, other categories of benefits–for example related to expectations around sexuality or mental well-being–may become more readily apparent to them. Interestingly, the comprehensive review of the literature undertaken by Young et al. (2013) before the wide rollout of PrEP found that willingness to take PrEP (the closest construct to motivations that they examined) was associated with younger age, unprotected anal intercourse with casual partners and increased risk perceptions; on the other side, anxieties around medical side effects of PrEP were commonly reported in the included studies as barriers. Psychosocial correlates of willingness, such as reduced anxiety about HIV infection or an increase in self-efficacy, do not appear to have been reported as frequently in this pre-rollout phase, however. While this may simply be an artefact of the biomedical approach to these questions taken by many of the studies included in their review, it might also support the hypothesis that these positive aspects of PrEP only become more readily apparent after PrEP use has been initiated. Some of our findings were surprising. Attitudes towards using PrEP have been shown in the literature to be linked to considerations of protecting primary and/or outside partners [73], and concerns for sexual partners’ risk of acquiring HIV and the public health have also been described as a facilitator of engaging in safer sex practices [74]. In our study, however, among the high number of respondents who reported some form of safety or protection against HIV as their only motivation or as one of their motivations (n = 154), only a few (n = 9) cited protecting their partners or relationships as a relevant motivational factor. One reason for this may be that a requirement for initiating PrEP, unlike using a condom, is that an individual gets tested for HIV. Knowing with greater certainty that they were not infected with HIV may have led them to focus more on the protective effects of PrEP for themselves rather than the thought of preventing onward transmission. Regardless, given the evidence that individuals are more averse to risk when their decisions affect others [74, 88, 89], focusing on risks to others to convince people to engage in beneficial public health behaviours remains an important part of public health messaging and initiatives. Moreover, the literature [37, 80, 90, 91] and anecdotal reports from the centres that took part in our study suggest that, increasingly, PrEP use is becoming a social norm and many individuals feel pressured to use PrEP in a social environment that insists on sex without condoms. Surprisingly, however, only one participant in our study mentioned this as a motivation for using or considering PrEP (“More and more guys are doing bareback sex only”). The reasons for this result are unclear, but may be related to an already long established culture of unprotected sex in subgroups of the gay population in large cities like Berlin, or to the fact that, at the time of our survey, PrEP had only just become available through formal channels in Germany. Regardless, the topic warrants further research, particularly of a qualitative nature. An important strength of our survey is that we asked participants explicitly about their motivation for considering or using PrEP rather than interpreting various factors correlated with PrEP contemplation or PrEP use as motivations. Another strength is its facility-based, multicentre design and paper format, which may have avoided or ameliorated some of the disadvantages of online surveys, such as self-selection bias and multiple responses from the same individuals. Nevertheless, our study also has a number of substantial limitations beyond its cross-sectional, observational design and the obvious caveats that this entails. First, the results of survey-based studies are subject to social desirability bias [American Journal of Sociology. 1972 ">92-96]. It is probable that some of our respondents indicated that their motivation for taking PrEP was safety because they wanted to project a favourable image of themselves or, despite the anonymous nature of the survey, they thought doing so would ensure continued good care from their physician or make it more likely they would obtain a prescription for PrEP. However, we found no statistically significant differences between the motivations reported by respondents who had a history of PrEP use and those who were considering it. Presumably individuals who had already taken PrEP before will have had fewer concerns about gaining access to the medication. Moreover, if reporting socially desirable motivations had been a strong force behind respondents’ answers, one might have expected, from both subgroups, a larger number of responses focusing on the protection of others or the public health more generally. Second, although our coding framework was developed and implemented in a systematic manner by three independent researchers, any set of codes and categories will always, to a certain extent, be arbitrary. We attempted to address this point by testing the assumption of independence of observations in larger and broader categories (as opposed to our subcategories), but it is possible that a different system of coding would yield different results. Third, due to our study being based on a paper survey with limited space for a free-text response, we were unable to pursue an important avenue of qualitative enquiry, namely in-depth follow-up questions leading from the general to the specific. Without this, it is impossible to know what the more superficial but also the deeper motivations for using or considering PrEP might be. In-depth interviews exploring our findings in future projects might bring more clarity. Fourth, respondents to our survey who indicated that they were neutral about or might be interested in taking PrEP but did not respond to our open question may have had different motivations than those who did provide a response. Our informal comparison of these two groups (see S1 Table) suggests that these individuals may have been less interested in PrEP because their self-perceived risk of HIV infection was lower due to their sexual risk behaviour (e.g., fewer anal sex partners and more condom use). Moreover, the findings of our study and the larger quantitative survey of which it is a part [30] are specific to MSM in Berlin and therefore limited in their generalisability. Nevertheless, they can provide a helpful comparison to the situation in cities with roughly similar populations of MSM such as London, San Francisco, Paris or New York, where the implementation of PrEP is already well underway. Fifth, because of space limitations in our paper-based survey we did not ask for explicit motivations for not using PrEP. Doing so would have added an interesting dimension to the study and allowed us to explore additional steps along the PrEP care continuum and approaches to promoting alternative prevention strategies. Sixth, although we did not exclude transgender MSM from taking part in our survey, we did not explicitly instruct participating centres to include or exclude this group. Anyone who identified as male (cis or trans) and reported having sex with other MSM could take part. Other sampling strategies could have been used to obtain meaningful data on transgender MSM’s motivations for using or considering PrEP but would have gone beyond the scope of our study.

Conclusion

As part of a broader multicentre survey of MSM in Berlin, Germany, we additionally asked participants in an open-ended question about their main motivation for using or considering the use of PrEP. While the focus of their responses lay on safety, the range of motivations was broad and could be grouped into five main categories, listed in descending order of frequency: safety and protection again HIV, mental well-being and quality of life, a desire or an intention to engage in sex without a condom, expectations about sexuality, and norms and social perspectives. There were no statistically significant differences in motivations between participants who were using PrEP already versus those who were considering its use. Many respondents reported several motivations, and responses overall were heterogeneous. This suggests that health professionals seeking, where appropriate, to increase PrEP uptake by focusing exclusively on its effectiveness in preventing HIV is unlikely to be as successful as a holistic approach that focuses on multiple motivating factors, particularly those related to mental health and quality of life. These results may inform health providers’ approach to PrEP education and prescribing, as well as the design of information campaigns and other interventions to increase PrEP uptake alongside other strategies of HIV prevention and support for the broader sexual and psychological health of MSM.

Demographic data and sexual risk behaviour of participants in analysis sample and participants who were neutral about or potentially interested in taking PrEP but who did not answer the question about their main motivation.

(DOCX) Click here for additional data file.

Minimal underlying data set and codebook.

Age of respondents has been removed to ensure patient anonymity. (XLSX) Click here for additional data file. 22 Jul 2021 PONE-D-21-17716 Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis – A mixed-methods analysis of data from a multicentre survey PLOS ONE Dear Dr. Gaskins, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers found the paper interesting and valuable, but they raised a number of important issues that need to be addressed. These include clarifying the study background and reframing the rationale; referencing and addressing a number of relevant studies that are omitted (in Intro and Discussion); more fully describing the methods and data analysi; and providing context on PrEP availability in Germany and the broader EU context for international readers. Please submit your revised manuscript by Sep 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Peter A Newman, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed the survey or questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. If the questionnaire is published, please provide a citation to the (1) questionnaire and/or (2) original publication associated with the questionnaire. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the opportunity to review “Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis – A mixed-methods analysis of data from a multi-centre survey”. The authors conducted a thorough analysis of both quantitative and qualitative data from a cross-sectional survey conducted with a relatively large sample of MSM with complete data on the qualitative component (n=228). The manuscript contributes to the broader literature about the importance of understanding social and structural factors in PrEP uptake. The authors’ conclusion that health professionals seeking to increase PrEP uptake need take a holistic approach that emphasizes multiple motivations is well-founded in their data. My enthusiasm for this manuscript is tempered by three major concerns. Specifically, the manuscript is in need of: 1) a more thorough literature review that draws on existing research about motivations for PrEP use; 2) clarification of the mixed-methods methodology; and 3) re-structuring of the methods/results. In addition to providing more details regarding these concerns, I offer some additional feedback by manuscript section below for the authors’ consideration. Abstract I’m not completely clear based on the results presented in the abstract how recognition of multiple and varied motivations may reassure practitioners concerned about condom use in relation to PrEP, particularly when the authors note that almost 1/5 intended not to use condoms. I would consider removing that line, as it requires too much context to be flushed out in an abstract in a nuanced way, but is explored in more depth in the discussion section of the manuscript. I’m unclear exactly what the authors mean by ‘categories’ in the sentence “…responses overall were heterogeneous, even within categories”; additional clarification would be most helpful. I appreciate the last line of the conclusion as a clear message for practitioners that is well-founded in the data. Introduction The authors strong opening paragraphs which detail the background of PrEP approval, the importance of PrEP to reducing HIV disparities particularly among MSM, and context of PrEP uptake in Berlin, Germany. In paragraph 2, it would be helpful for the authors to hypothesize or provide data pertaining to why those who were likely to use PrEP were not able to access it. I would also be interested to know a bit more about why policy makers in many countries are debating integration of PrEP into publicly-funded systems, but recognize that this may be beyond the scope of the paper. In between the lines starting “As of late 2019…” and “This is unfortunate…” it would be helpful to add one line and associated references that refers to the disproportionate prevalence of HIV among MSM in the US context (see: https://www.cdc.gov/hiv/group/msm/index.html). In terms of flow, I would consider switching the order of paragraphs 3 on the PrEP continuum of care and paragraph 4 on barriers to PrEP uptake. I appreciate the authors’ attentiveness to social and structural barriers to PrEP uptake and considerations of a PrEP continuum of care. To that end, there is some literature that should be integrated into the PrEP continuum of care paragraph as well as used to contextualize the discussion. Please see: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253066/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315535/ https://journals.lww.com/jaids/Abstract/2021/04150/The_PrEP_Cascade_in_a_National_Cohort_of.4.aspx?context=LatestArticles While the latter two articles follow more biomedically-oriented conceptualizations of a PrEP cascade, the first article (Newman et al., 2018) details social and structural considerations of PrEP uptake across a PrEP continuum of care, some of which overlaps with the findings of this manuscript. Moreover, given the topic of the paper is on motivations of PrEP use, I believe that the sentence “However, our knowledge about explicit motivations that influence decisions to initiate PrEP is less well developed and stems mostly from small qualitative studies involving focus groups or interviews [38-42]” warrants it’s own paragraph and more details. There is also additional research on motivations for PrEP use, some of which corroborates the findings of the researchers, that could be integrated into the introduction and the discussion, for example: https://sti.bmj.com/content/95/4/262.abstract https://academic.oup.com/abm/article/49/2/177/4561523?login=true Then, it may be helpful to add one additional statement explicitly summarizing gaps in the evidence base. Minor notes: line 78 at first mention of United States include US in brackets, as you use US throughout after that; also, MSM should be spelled out at first mention. Materials and Methods I appreciated the thorough overview of recruitment, and in particular the in-depth description of the non-municipal counselling and testing centers and HIV specialist services. Was there a rationale for randomly selecting 30 out of 228 responses to create the coding framework? For example, did the authors reach some level of saturation (no new category generation) by open-text response 30? Upon coding the remaining free-text responses, were there any motivations that did not fit within the originally-developed framework? If so, how did the authors resolve this? In terms of structure, I believe it would be clearer if the sub-heading ‘Literature search’ was removed and the literature search paragraph integrated into the analysis section before the line “These two classifications systems…”. Moreover, the operationalization of the PrEP care continuum is related to the quantitative analysis and could be absolved into that section before the line beginning with “For any post-hoc pairwise comparisons…” Table 1: I appreciate the authors’ integration of references. Some of the suggested references above may also be able to be integrated into the table so that there are references for most of the sub-categories (E.g., Newman et al. (2018) could be used to reference ‘expectations of more pleasureful sex or increased intimacy and closeness (when not using a condom)’, ‘ expectations of worry-free sex’, ‘desire to increase quality of life or sexual/personal freedom’, ‘reducing anxiety, fear, or worries of being infected with HIV’, and ‘autonomy and self-empowerment in the protection against HIV’, among other sub-categories. One aspect I wondered about in the Abstract, and now here, is the potential overlap between ‘worry-free sex’ and ‘reducing anxiety, fear, or worries of being infected with HIV’ – can the authors expand more on how they are conceptualizing the difference between these sub-categories throughout the manuscript. For clarity, I suggest using the sub-headings ‘Qualitative data analysis’ (for section that is now called Data analysis) and then ‘Quantitative data analysis’ (for the section that is now called Sample size and statistical methods). The way that the study is currently depicted is as a multi-method as opposed to a mixed-methods study. Mixed methods is an in-depth methodology that goes beyond the rigorous collection and analysis of both quantitative and qualitative data to include the integration of the two forms of data using a pre-specified mixed methods typology (See: Creswell & Plano-Clark, 2017), thus, more details about the mixed-methods methodology should be included. As the key to mixed-methods is integration of quantitative and qualitative data, if mixed-methods is maintained as the methodology, another section should be added titled ‘Mixed methods analysis’ that details how quantitative and qualitative data were compared/contrasted (See: Fetters, Curry, & Creswell, 2013). Alternately, the authors may opt to refer to their study as a multi-method study Minor: Please spell in full at first use of LGBTI+. Results The first paragraph of the results could be integrated within the methods section ‘Sampling methods, participants, and settings’, up until the last line; the last line could be included in the section ‘Demographic data, sexual behavior, and HIV risk of analysis sample’. Table 2 – rows with 0 responses (e.g., primary education, small town/rural area in Germany) could be omitted. The lines “There was a high degree of agreement between the coding results…” should be integrated within the qualitative data analysis sub-section. The subsection coding of responses could be more appropriately titled Motivations of Participants (or something similar). I don’t think the line “there were no disagreements between the reviewers in this regard” is needed – if maintained, it should also be moved to the analysis. I may have missed it, but I’m not clear how the authors classified a motivation as a main motivation – does this just mean that the participant wrote it down as a motivation, or did the authors denote some order as to what was main when participants indicated more than one motivation? Please clarify. Discussion I am wondering if the authors have more context about provider concern about condom use as leading to hesitancy about PrEP – is this an issue in the EU context that has prevented widespread adoption of PrEP into public insurance plans? Additional references would be helpful. The authors may also consider a broader discussion of literature pertaining to PrEP counselling from a holistic lens, as they are describing, see: https://academic.oup.com/hsw/article-abstract/46/1/22/6151208 https://link.springer.com/article/10.1007/s10461-020-02855-9 https://www.tandfonline.com/doi/abs/10.1080/09540121.2020.1744507 Excellent overview of the limitations of the study. Reviewer #2: This paper reviews the motivations for PrEP use among a sample of MSM living in Berlin. It is methodologically sound and well-written with some thought-provoking conclusions, particularly with respect to the mental health circumstances of MSM and how these may be alleviated, for some, by the use PrEP. There are, however, a few issues that I think need to be addressed before it is ready for publication. 1. Recognising and reflecting previous research. The emergence of PrEP has seen a significant number of papers published that examine: the acceptability of PrEP; motivations for PrEP use; factors that may influence PrEP uptake and continued use; how PrEP is integrated into sexual lives; how PrEP reforms how MSM think about HIV risk, etc. As the key rationale for the study, the authors states that most prior research has been focus group or interview based and, therefore, larger scale data is required. I’m not sure this accurately reflects the nature of the literature on this topic (where there are a number of quantitative or survey-based studies) nor does being ‘bigger’ necessarily constitute a clear rationale for this study. I would encourage the authors to acknowledge the large amount of quantitative literature on this topic (look, for example, at work by Bavinton, Prestage and Holt, among others) and consider recasting the principle rationale for the study to identify what is unique. 2. Acceptable in theory and in practice. Partially linked to the point above, prior to the widespread rollout of PrEP there were a large number of studies looking at the theoretical acceptability of PrEP (see review by Ingrid Young). What I found myself wondering was how the findings of your study – when people CAN actually access and use PrEP differ from/relate to the motivations MSM provided when talking about PrEP in the abstract. Can you reflect some of this literature in your discussion? 3. Coding frame. Can you provide a clear rationale as to why you created a coding frame from a review of the literature and applied it to your data, rather than working with the data in an inductive manner? I also think it would be much easier to follow if you describe the literature review process, and its purpose, prior to presenting the coding frame. 4. As a minor point, can you include a short summary as to the status of PrEP availability in Germany a the time of data collection? Where could it be obtained? How much did it cost? What prescribing criteria has to be met? Such information would aid interpretation from an international audience. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 8 Sep 2021 Dear Professor Newman, Dear members of the Editorial Board, Dear Reviewers, We would like to thank the academic editor and each of the reviewers for their careful review of our manuscript and their thorough and very helpful suggestions for improving it. We feel that the manuscript has benefitted greatly as a result. Please find our replies to each of their points in the rebuttal letter we have uploaded, including details on how we have implemented their suggestions. Please note that all line numbers in the rebuttal letter refer to the file ‘Revised Manuscript with Track Changes’. (If the reviewers prefer that the line numbers refer to the clean file without track changes, we would be happy to send a revised point-by-point reply letter with these instead.) Yours sincerely, Matthew Gaskins Submitted filename: Response to Reviewers.docx Click here for additional data file. 4 Nov 2021 Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis – A multi-methods analysis of data from a multicentre survey PONE-D-21-17716R1 Dear Dr. Gaskins, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Peter A Newman, Ph.D Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the opportunity to re-review the manuscript now titled “Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis – A multi-methods analysis of data from a multi-centre study”. The authors have addressed my comments to a high degree of quality. I agree with the authors' assessment that the expanded literature review leads into a clearer rationale for the study, both from a methodological and study site (geographic) perspective. The methodology is now clearer as described as a multi-methods study. The added description of qualitative analyses and restructuring of the methods (particularly moving the section previously entitled literature review) has also strengthened the clarity of the manuscript. I just have one minor comment: Where the authors quote Young & McDaid in the introduction a page number is needed. Reviewer #2: I congratulate the authors on a really comprehensive revision of their manuscript. The integration of existing research, coupled with a reflection on how PrEP is perceived in practice (rather than just in theory) has helped to ensure a much more convincing rationale for the paper. The methodology is also much more clear now that the inductive-deductive process of data coding has been explained in more detail. It makes a useful addition to the literature on this topic. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Adam Bourne 9 Nov 2021 PONE-D-21-17716R1 Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis – A multi-methods analysis of data from a multicentre survey Dear Dr. Gaskins: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Peter A Newman Academic Editor PLOS ONE
  79 in total

1.  Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada.

Authors:  Maile Y Karris; Susan E Beekmann; Sanjay R Mehta; Christy M Anderson; Philip M Polgreen
Journal:  Clin Infect Dis       Date:  2013-12-06       Impact factor: 9.079

2.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

3.  Using preexposure prophylaxis, losing condoms? Preexposure prophylaxis promotion may undermine safe sex.

Authors:  Kamair Alaei; Christopher A Paynter; Shao-Chiu Juan; Arash Alaei
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

4.  For the greatest impact, end caps on PrEP access now.

Authors: 
Journal:  Lancet HIV       Date:  2019-01-24       Impact factor: 12.767

Review 5.  Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior.

Authors:  J A Catania; D R Gibson; D D Chitwood; T J Coates
Journal:  Psychol Bull       Date:  1990-11       Impact factor: 17.737

6.  Geographic Access to Preexposure Prophylaxis Clinics Among Men Who Have Sex With Men in the United States.

Authors:  Aaron J Siegler; Anna Bratcher; Kevin M Weiss
Journal:  Am J Public Health       Date:  2019-07-18       Impact factor: 9.308

7.  No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.

Authors:  Jonathan E Volk; Julia L Marcus; Tony Phengrasamy; Derek Blechinger; Dong Phuong Nguyen; Stephen Follansbee; C Bradley Hare
Journal:  Clin Infect Dis       Date:  2015-09-01       Impact factor: 9.079

8.  Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study.

Authors:  Roman Shrestha; Frederick L Altice; Pramila Karki; Michael M Copenhaver
Journal:  AIDS Behav       Date:  2018-08

Review 9.  Improving PrEP Implementation Through Multilevel Interventions: A Synthesis of the Literature.

Authors:  Rogério M Pinto; Kathryn R Berringer; Rita Melendez; Okeoma Mmeje
Journal:  AIDS Behav       Date:  2018-11

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.